Establishment and directed differentiation of induced pluripotent stem cells from glycogen storage disease type Ib patient

Daisuke Satoh, Tohru Maeda, Tetsuya Ito, Yoko Nakajima, Mariko Ohte, Akane Ukai, Katsunori Nakamura, Shin Enosawa, Masashi Toyota, Yoshitaka Miyagawa, Hajime Okita, Nobutaka Kiyokawa, Hidenori Akutsu, Akihiro Umezawa, Tamihide Matsunaga

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Glycogen storage disease type Ib (GSDIb) is caused by a deficiency in the glucose-6-phosphate transporter (G6PT), which leads to neutrophil dysfunction. However, the underlying causes of these dysfunctions and their relationship with glucose homeostasis are unclear. Induced pluripotent stem cells (iPSCs) hold a great promise for advances in developmental biology, cell-based therapy and modeling of human disease. Here, we examined the use of iPSCs as a model for GSDIb. In this study, one 2-year-old patient was genetically screened and diagnosed with GSDIb. We established iPSCs and differentiated these cells into hepatocytes and neutrophils, which comprise the main pathological components of GSDIb. Cells that differentiated into hepatocytes exhibited characteristic albumin secretion and indocyanine green uptake. Moreover, iPSC-derived cells generated from patients with GSDIb metabolic abnormalities recapitulated key pathological features of the diseases affecting the patients from whom they were derived, such as glycogen, lactate, pyruvate and lipid accumulation. Cells that were differentiated into neutrophils also showed the GSDIb pathology. In addition to the expression of neutrophil markers, we showed increased superoxide anion production, increased annexin V binding and activation of caspase-3 and caspase-9, consistent with the GSDIb patient's neutrophils. These results indicate valuable tools for the analysis of this pathology and the development of future treatments.

Original languageEnglish
Pages (from-to)1053-1069
Number of pages17
JournalGenes to Cells
Volume18
Issue number12
DOIs
Publication statusPublished - 2013 Dec
Externally publishedYes

Fingerprint

Glycogen Storage Disease
Induced Pluripotent Stem Cells
Neutrophils
Hepatocytes
Pathology
Developmental Biology
Indocyanine Green
Caspase 9
Annexin A5
Cell- and Tissue-Based Therapy
Pyruvic Acid
Glycogen
Superoxides
Caspase 3
Albumins
Lactic Acid
Homeostasis
Lipids
Glucose

ASJC Scopus subject areas

  • Genetics
  • Cell Biology

Cite this

Satoh, D., Maeda, T., Ito, T., Nakajima, Y., Ohte, M., Ukai, A., ... Matsunaga, T. (2013). Establishment and directed differentiation of induced pluripotent stem cells from glycogen storage disease type Ib patient. Genes to Cells, 18(12), 1053-1069. https://doi.org/10.1111/gtc.12101

Establishment and directed differentiation of induced pluripotent stem cells from glycogen storage disease type Ib patient. / Satoh, Daisuke; Maeda, Tohru; Ito, Tetsuya; Nakajima, Yoko; Ohte, Mariko; Ukai, Akane; Nakamura, Katsunori; Enosawa, Shin; Toyota, Masashi; Miyagawa, Yoshitaka; Okita, Hajime; Kiyokawa, Nobutaka; Akutsu, Hidenori; Umezawa, Akihiro; Matsunaga, Tamihide.

In: Genes to Cells, Vol. 18, No. 12, 12.2013, p. 1053-1069.

Research output: Contribution to journalArticle

Satoh, D, Maeda, T, Ito, T, Nakajima, Y, Ohte, M, Ukai, A, Nakamura, K, Enosawa, S, Toyota, M, Miyagawa, Y, Okita, H, Kiyokawa, N, Akutsu, H, Umezawa, A & Matsunaga, T 2013, 'Establishment and directed differentiation of induced pluripotent stem cells from glycogen storage disease type Ib patient', Genes to Cells, vol. 18, no. 12, pp. 1053-1069. https://doi.org/10.1111/gtc.12101
Satoh, Daisuke ; Maeda, Tohru ; Ito, Tetsuya ; Nakajima, Yoko ; Ohte, Mariko ; Ukai, Akane ; Nakamura, Katsunori ; Enosawa, Shin ; Toyota, Masashi ; Miyagawa, Yoshitaka ; Okita, Hajime ; Kiyokawa, Nobutaka ; Akutsu, Hidenori ; Umezawa, Akihiro ; Matsunaga, Tamihide. / Establishment and directed differentiation of induced pluripotent stem cells from glycogen storage disease type Ib patient. In: Genes to Cells. 2013 ; Vol. 18, No. 12. pp. 1053-1069.
@article{5b781952cbb74e35bbd16a8bf4d78026,
title = "Establishment and directed differentiation of induced pluripotent stem cells from glycogen storage disease type Ib patient",
abstract = "Glycogen storage disease type Ib (GSDIb) is caused by a deficiency in the glucose-6-phosphate transporter (G6PT), which leads to neutrophil dysfunction. However, the underlying causes of these dysfunctions and their relationship with glucose homeostasis are unclear. Induced pluripotent stem cells (iPSCs) hold a great promise for advances in developmental biology, cell-based therapy and modeling of human disease. Here, we examined the use of iPSCs as a model for GSDIb. In this study, one 2-year-old patient was genetically screened and diagnosed with GSDIb. We established iPSCs and differentiated these cells into hepatocytes and neutrophils, which comprise the main pathological components of GSDIb. Cells that differentiated into hepatocytes exhibited characteristic albumin secretion and indocyanine green uptake. Moreover, iPSC-derived cells generated from patients with GSDIb metabolic abnormalities recapitulated key pathological features of the diseases affecting the patients from whom they were derived, such as glycogen, lactate, pyruvate and lipid accumulation. Cells that were differentiated into neutrophils also showed the GSDIb pathology. In addition to the expression of neutrophil markers, we showed increased superoxide anion production, increased annexin V binding and activation of caspase-3 and caspase-9, consistent with the GSDIb patient's neutrophils. These results indicate valuable tools for the analysis of this pathology and the development of future treatments.",
author = "Daisuke Satoh and Tohru Maeda and Tetsuya Ito and Yoko Nakajima and Mariko Ohte and Akane Ukai and Katsunori Nakamura and Shin Enosawa and Masashi Toyota and Yoshitaka Miyagawa and Hajime Okita and Nobutaka Kiyokawa and Hidenori Akutsu and Akihiro Umezawa and Tamihide Matsunaga",
year = "2013",
month = "12",
doi = "10.1111/gtc.12101",
language = "English",
volume = "18",
pages = "1053--1069",
journal = "Genes to Cells",
issn = "1356-9597",
publisher = "Wiley-Blackwell",
number = "12",

}

TY - JOUR

T1 - Establishment and directed differentiation of induced pluripotent stem cells from glycogen storage disease type Ib patient

AU - Satoh, Daisuke

AU - Maeda, Tohru

AU - Ito, Tetsuya

AU - Nakajima, Yoko

AU - Ohte, Mariko

AU - Ukai, Akane

AU - Nakamura, Katsunori

AU - Enosawa, Shin

AU - Toyota, Masashi

AU - Miyagawa, Yoshitaka

AU - Okita, Hajime

AU - Kiyokawa, Nobutaka

AU - Akutsu, Hidenori

AU - Umezawa, Akihiro

AU - Matsunaga, Tamihide

PY - 2013/12

Y1 - 2013/12

N2 - Glycogen storage disease type Ib (GSDIb) is caused by a deficiency in the glucose-6-phosphate transporter (G6PT), which leads to neutrophil dysfunction. However, the underlying causes of these dysfunctions and their relationship with glucose homeostasis are unclear. Induced pluripotent stem cells (iPSCs) hold a great promise for advances in developmental biology, cell-based therapy and modeling of human disease. Here, we examined the use of iPSCs as a model for GSDIb. In this study, one 2-year-old patient was genetically screened and diagnosed with GSDIb. We established iPSCs and differentiated these cells into hepatocytes and neutrophils, which comprise the main pathological components of GSDIb. Cells that differentiated into hepatocytes exhibited characteristic albumin secretion and indocyanine green uptake. Moreover, iPSC-derived cells generated from patients with GSDIb metabolic abnormalities recapitulated key pathological features of the diseases affecting the patients from whom they were derived, such as glycogen, lactate, pyruvate and lipid accumulation. Cells that were differentiated into neutrophils also showed the GSDIb pathology. In addition to the expression of neutrophil markers, we showed increased superoxide anion production, increased annexin V binding and activation of caspase-3 and caspase-9, consistent with the GSDIb patient's neutrophils. These results indicate valuable tools for the analysis of this pathology and the development of future treatments.

AB - Glycogen storage disease type Ib (GSDIb) is caused by a deficiency in the glucose-6-phosphate transporter (G6PT), which leads to neutrophil dysfunction. However, the underlying causes of these dysfunctions and their relationship with glucose homeostasis are unclear. Induced pluripotent stem cells (iPSCs) hold a great promise for advances in developmental biology, cell-based therapy and modeling of human disease. Here, we examined the use of iPSCs as a model for GSDIb. In this study, one 2-year-old patient was genetically screened and diagnosed with GSDIb. We established iPSCs and differentiated these cells into hepatocytes and neutrophils, which comprise the main pathological components of GSDIb. Cells that differentiated into hepatocytes exhibited characteristic albumin secretion and indocyanine green uptake. Moreover, iPSC-derived cells generated from patients with GSDIb metabolic abnormalities recapitulated key pathological features of the diseases affecting the patients from whom they were derived, such as glycogen, lactate, pyruvate and lipid accumulation. Cells that were differentiated into neutrophils also showed the GSDIb pathology. In addition to the expression of neutrophil markers, we showed increased superoxide anion production, increased annexin V binding and activation of caspase-3 and caspase-9, consistent with the GSDIb patient's neutrophils. These results indicate valuable tools for the analysis of this pathology and the development of future treatments.

UR - http://www.scopus.com/inward/record.url?scp=84888329754&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84888329754&partnerID=8YFLogxK

U2 - 10.1111/gtc.12101

DO - 10.1111/gtc.12101

M3 - Article

VL - 18

SP - 1053

EP - 1069

JO - Genes to Cells

JF - Genes to Cells

SN - 1356-9597

IS - 12

ER -